Neurocrine Biosciences Inc.

NASDAQ: NBIX
Share price (3/25/25): $116.18
Market cap (3/25/25): $11.6 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Amendment to registration of securities for employees

Registration of securities for employees

Ownership Filter

Vanguard Group Inc

Gorman Kevin Charles

Sherwin Stephen A

News Filter

Reports Fourth Quarter and Fiscal 2024 Financial Results and Provides Financial Expectations for 2025

Announces Amendment to Strategic Collaboration With Takeda to Develop and Commercialize Osavampator

Announces Commercial Availability of CRENESSITY™ (Crinecerfont) for Children and Adults With Classic Congenital Adrenal Hyperplasia

Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Confidential treatment order

Letter from the SEC